1. Addington DE, Towes JA, Addington JM (1995) Risperidone and tardive dyskinesia; a case report. J Clin Psychiatry 56:484–485
2. Ames D, Wirshing WC, Marder SR (1996) Advances in antipsychotic pharmacotherapy: clozapine, risperidone, and beyond. Essent Psychopharmacol 1:5–26
3. Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S, The Olanzapine HGAD Study Group (1996) Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:111–123
4. Borison RL, Pathiraja AP, Diamond BI, Meibach RC (1992) Risperidone: clinical safety and efficacy in schizophrenia. Psychopharmacol Bull 28:213–218
5. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87–96